Longitudinal evidence on punctal plug use in an elderly population

Ophthalmic Plastic and Reconstructive Surgery

Volumn 28, Issue 4, 2012, Pages 289-293

  Chi, Sulene L ^a   Acquah, Kofi F ^b   Richard, Michael J ^a   Lee, Paul P ^c   Sloan, Frank A ^d  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

AGED; ARTICLE; DRY EYE; EYE PROTECTIVE DEVICE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICARE; PRIORITY JOURNAL; PUNCTAL PLUG; REIMBURSEMENT;

AGED; DRY EYE SYNDROMES; HUMANS; LACRIMAL APPARATUS; LONGITUDINAL STUDIES; MEDICARE PART B; PHYSICIAN'S PRACTICE PATTERNS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; REIMBURSEMENT MECHANISMS; SURGICAL INSTRUMENTS; UNITED STATES;

EID: 84863975463     PISSN: 07409303     EISSN: 15372677     Source Type: Journal    
DOI: 10.1097/IOP.0b013e31825ca599     Document Type: Article

References (27)

1. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318-26.
2. American Academy of Ophthalmology Preferred Practice Pattern. September. 2008. Available at: www.aao.org/ppp. Accessed April 26, 2012.
3. Schaumberg DA, Dana R, Buring JE, et al. Prevalence of dry eye disease among US men: Estimates from the Physicians Health Studies. Arch Ophthalmol 2009;127:763-8.
4. Schein OD, Muñoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723-8.
5. Miljanovic B, Dana R, Sullivan DA, et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007;143:409-15.
6. Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology 2003;110:1412-9.
7. Doughty MJ, Fonn D, Richter D, et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci 1997;74:624-31.
8. Goto E, Yagi Y, Matsumoto Y, et al. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol 2002;133:181-6.
9. Liu Z, Pflugfelder SC. Corneal thickness is reduced in dry eye. Cornea 1999;18:403-7.
10. Rolando M, Iester M, Macrí A, et al. Low spatial-contrast sensitivity in dry eyes. Cornea 1998;17:376-9.
11. Calonge M. The treatment of dry eye. Surv Ophthalmol 2001;45 Suppl 2:S227-39.
12. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: A twenty-five-year review. Cornea 2000;19:644-9.
13. Ervin AM, Wojciechowski R, Schein O. Punctal occlusion for dry eye syndrome. Cochrane Database Syst Rev 2010:CD006775.
14. Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: A decision tree analysis. Cornea 2011;30:379-87.
15. McGuire TG, Pauly MV. Physician response to fee changes with multiple payers. J Health Econ 1991;10:385-410.
16. Chang SL, Liao JC, Shinghal R. Decreasing use of luteinizing hormone-releasing hormone agonists in the United States is Independent of Reimbursement Changes: A Medicare and Veterans Health Administration claims analysis. J Urol 2009;182:255-60; discussion 261.
17. Gross CP, Andersen MS, Krumholz HM, et al. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA 2006;296:2815-22.
18. Jacobson M, OMalley AJ, Earle CC, et al. Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) 2006;25:437-43.
19. Lee AJ, Mitchell JB. Physician reaction to price changes: An episode-of-care analysis. Health Care Financ Rev 1994;16:65-83.
20. Mitchell JM, Hadley J, Gaskin DJ. Physicians responses to Medicare fee schedule reductions. Med Care 2000;38:1029-39.
21. Mitchell JM, Hadley J, Gaskin DJ. Spillover effects of Medicare fee reductions: Evidence from ophthalmology. Int J Health Care Finance Econ 2002;2:171-88.
22. Donnenfeld E, Pflugfelder SC. Topical ophthalmic cyclosporine: Pharmacology and clinical uses. Surv Ophthalmol 2009;54:321-38.
23. Kymionis GD, Bouzoukis DI, Diakonis VF, et al. Treatment of chronic dry eye: Focus on cyclosporine. Clin Ophthalmol 2008;2:829-36.
24. Allergan Inc. Earnings Release 2003-2009. Available at: http://agn.client.shareholder.com/earnings.cfm. Accessed May 21, 2012.
25. Horwath-Winter J, Thaci A, Gruber A, et al. Long-term retention rates and complications of silicone punctal plugs in dry eye. Am J Ophthalmol 2007;144:441-4.
26. Roberts CW, Carniglia PE, Brazzo BG. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye. Cornea 2007;26:805-9.
27. Fiscella RG, Lee JT, Walt JG, et al. Utilization characteristics of topical cycolsporine and punctal plugs in a managed care database. Am J Manag Care 2008;14(3 Suppl):S107-12.